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Abstract 
Background: Data from RNA‑seq experiments provide a wealth of information about the transcriptome of an 
organism. However, the analysis of such data is very demanding. In this study, we aimed to establish robust analysis 
procedures that can be used in clinical practice.
Methods: We studied RNA‑seq data from triple‑negative breast cancer patients. Specifically, we investigated the 
subsampling of RNA‑seq data.
Results: The main results of our investigations are as follows: (1) the subsampling of RNA‑seq data gave biologically 
realistic simulations of sequencing experiments with smaller sequencing depth but not direct scaling of count matri‑
ces; (2) the saturation of results required an average sequencing depth larger than 32 million reads and an individual 
sequencing depth larger than 46 million reads; and (3) for an abrogated feature selection, higher moments of the 
distribution of all expressed genes had a higher sensitivity for signal detection than the corresponding mean values.
Conclusions: Our results reveal important characteristics of RNA‑seq data that must be understood before one can 
apply such an approach to translational medicine.
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Background
In recent years, next-generation sequencing technology 
for generating RNA-seq data has gained considerable 
interest [1–4] in the biological [5, 6] and biomedical liter-
ature [7, 8]. Such data are frequently used, e.g., for identi-
fying alternative splicing, finding differentially expressed 
genes, or detecting differentially expressed pathways 
[9–14]. The conventional analysis pipeline for RNA-seq 
data first maps the reads to genes for a given annotation, 
resulting in a high-dimensional count vector for each 
sample. Thereafter, these integer count vectors are nor-
malized and further processed with statistical inference 
methods. Altering parameters of the preprocessing steps, 
e.g., aligning procedure, summarization of reads, choice 
of annotation, and normalization techniques, can change 
the output of a gene expression analysis drastically. This 
effect has been studied for different normalization pro-
cedures [15].
So far, a major focus has been placed on methods for 
identifying differentially expressed genes from RNA-seq 
data [16–18] because such analysis methods that are sim-
pler than, e.g., network-based approaches yet provide 
meaningful insights into the basic biological function-
ing of different physiological conditions. Some of these 
methods assume that the count distribution of individ-
ual genes follows a Poisson distribution, whereas others 
assume a negative binomial distribution for their model. 
Interestingly, it has been argued that the negative bino-
mial distribution does not perform well under specific 
conditions [18].
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In this study, we carried out an analysis of RNA-seq 
count distributions for two biological conditions: triple-
negative breast cancer (TNBC) samples and TNBC-free 
samples. The TNBC-free samples corresponded to the 
same cell types as TNBC samples but were from nor-
mal tissue; they formed a control group. For each bio-
logical sample, we repeatedly performed a subsampling 
of mapped reads and thus simulated new samples with 
a different sequencing depth. For these surrogate gene 
expression data sets, we studied and compared a variety 
of properties of their RNA-seq count distributions. We 
describe the biological data we used for our analysis and 
the preprocessing steps we applied, and we introduce a 
procedure, Depth of Sequencing Iterative Reduction Esti-
mator (DESIRE), for subsampling RNA-seq data.
Methods
Dataset
The whole data set consists of 6 groups, including a total 
of 168 samples [19]. We randomly selected four samples 
of TNBC tumors from the primary tumor group and four 
samples of healthy breast tissues from TNBC-free group. 
This selection allowed us to estimate the main statistical 
entities under investigation. Other samples were not con-
sidered in our analysis.
Data preprocessing
To use RNA-seq data for a gene expression analysis, 
certain preprocessing steps must be performed. These 
include alignment of reads, count matrix computation, 
and normalization.
After the data were extracted from The Sequence Read 
Archive [20], we performed the alignment with Bow-
tie 2 [21] allowing 1 mismatch; human genome version 
hg38 [22] was taken as the most recent version of refer-
ence at the time when the analysis was conducted. To 
obtain a count vector for a sample (i.e., the number of 
reads mapped to a gene for all genes), we used the fea-
tureCounts function available from the Rsubread pack-
age for the R language [23]. During this procedure, the 
total number of fragments mapped to particular gene 
positions was summarized. We followed the steps usually 
implemented for differential gene expression analysis, so 
various gene isoforms were not of interest. We focused 
on the gene level for the summarization, not the exon 
level. The overall process is shown in Fig. 1.
In recent years, a number of different normalization 
methods have been suggested for the modification of the 
integer counts for the genes [15]. We preferred “counts 





over “reads per kilobase per million” (RPKM) [24], given 
by
Here, i corresponds to the index of a gene; Ni is the num-
ber of integer counts (reads) for gene i; Nlib is the total 
number of reads in the library, i.e., the total number 
of reads per sample; and Li is the length of an exon (in 
kilobases).
When choosing CPM, we followed the reported argu-
ment [18] as the relative difference in expression levels 
between conditions was the matter of interest.
Depth of sequencing iterative reduction estimator 
(DESIRE)
It is commonly accepted that the depth of the sequenc-
ing can affect the results of an analysis [25–28]. However, 
these papers considered only results of a bioinformatics 
analysis and did not study the details of the count distri-
butions. Another example is the study that addressed the 
question of the optimal sequencing depth [29].
To study the influence of the sequencing depth on a 
gene expression analysis, we developed a resampling 
procedure based on the subsampling of the data. By 
subsampling, we used only a fraction, f, of the total 
amount of available data in a systematic manner [30]. 
Another name for such a procedure used in the liter-
ature is m out of n bootstrap, whereas m  <  n and the 
bootstrap samples are drawn without replacement [31]. 











Fig. 1 Preprocessing steps of our analysis. Short reads as provided in 
Fastq files are aligned with Bowtie 2, resulting in Sam files. Application 
of our method Depth of Sequencing Iterative Reduction Estimator 
(DESIRE) extracts a defined subsample of size f, resulting in updated 
Sam files. Finally, feature Counts, a function from the R subread pack‑
age, is applied to obtain the count vector for one sample.
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For each biological sample, we drew a number of repli-
cates of a smaller sequencing depth. To accomplish this, 
a particular portion, f, of reads, ranging from 10 to 90%, 
was randomly drawn from a biological sample without 
replacement. This process was repeated R times resulting 
in R simulated replicates for one simulated sequencing 
depth f. For our analysis, we used R =  24 resulting in a 
total of 240 subsampled data sets for a single biological 
sample for the 10 different sequencing depths, f = {0.1,…, 
0.9, 1.0}.
The specific value of R is not crucial. However, if it is 
large, the computational complexity would increase with-
out resulting in significant improvements in the statisti-
cal estimates of our analysis. On the other hand, values 
of R much lower than 24 potentially result in unstable 
results. The particular number of R = 24 considered the 
number of nodes in our computer cluster available for 
our analysis.
A schematic overview of the DESIRE procedure is 
shown in Figs.  2 and 3. It is important to note that the 
simulated sequencing death, f, refers to all reads of the 
genome and not to the reads of a single gene. In this 
way, DESIRE simulates actual biological experiments 
conducted for a smaller sequencing depth. If we draw f 
reads for each gene independently, the resulting sam-
ples would not correspond to results produced by next-
generation sequencing technology, e.g., on an Illumina 
platform.
We calculated the count vectors using Entrez annota-
tion from Bioconductor, database org.Hs.e.g.db2.9.0, 
which consisted of 23,648 (protein-coding and -noncod-
ing) genes [32].
Results
The purpose of our study was to learn about the influence 
of the sequencing depth on inferred biological results. 
For this reason, we investigated 4 layers of complexity. 
First, we compared differences between an explicit sub-
sampling of reads and a direct scaling of count matrices. 
The results from this analysis demonstrated that a sub-
sampling via DESIRE was necessary to obtain realistic 
surrogates of sequencing experiments with a smaller 
sequencing depth. Second, we studied the absolute 
expression of genes and their growth. Third, we investi-
gated the growth rate of the number of expressed genes. 
Fourth, we analyzed differences in the distributional 
Fig. 2 Overview of the DESIRE procedure.
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shape of expressed genes between TNBC patients and 
TNBC-free patients. For each of these analysis steps, we 
used data generated by the DESIRE procedure.
Differences between subsampling of reads and direct 
scaling of count matrices
Our first analysis investigated differences between a sub-
sampling of reads via the DESIRE procedure and a direct 
scaling of count matrices. The results of this analysis jus-
tified our approach for the following sections.
The basic idea of DESIRE is to draw randomly aligned 
reads, as provided by a Sam file, and create a new auxil-
iary Sam file corresponding to a new sequencing experi-
ment with a smaller sequencing depth. We compared 
this with a direct scaling of count matrices, whereas the 
scaling was obtained by multiplying the components of 
the count matrices, cij, with a constant factor f that corre-
sponds to the simulated sequencing depth because
Hence, this simple scaling of a count matrix resulted in 
the desired simulated sequencing depth for a sample.
For one TNBC-free sample (SRR1313211), the differ-
ence between counts obtained via our DESIRE procedure 
and the direct scaling method of count matrices is shown 
in Fig. 4. Specifically, the number of expressed genes (Y 
axis), depending on the sequencing depth f (X axis), for 
different values of a threshold parameter is presented 
(4)
Total number of scaled counts
Total number of counts
=
∑
i,j f × cij∑
i,j cij
= f
Fig. 3 Generation of R replicates for a given sequencing depth using only a fraction, f, of the original data in a biological sample. Hence, each of the 
R generated data sets is a subsample of the original biological sample.
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in Fig.  4. By the number of expressed genes, we meant 
the number of genes that have a short read count cij of 
⊝ϵ{1, 10, 50, 100} or larger, i.e., cij ≥ ⊝, where ⊝ is the 
threshold parameter. All results are for raw count values, 
not normalized values, and each dot corresponds to the 
result from one data set.
For all threshold values and all sequencing depths that 
we investigated, there were distinct differences between 
the two approaches (Fig.  4). Similar results were also 
observed in other patient samples (not shown). From 
these results, we concluded that the computationally effi-
cient shortcut via a direct scaling of count matrices did 
not lead to the same results as the DESIRE procedure. 
Hence, the scaled count matrices did not correspond to 
sequencing experiments with a smaller sequencing depth 
but had an unclear biological interpretation. For this rea-
son, the DESIRE procedure needs to be used for simulat-
ing realistic sequencing experiments because only in this 
way do the resulting data have a clear interpretation in 
biological terms. In the following sections, we used the 
DESIRE procedure for this purpose.
We would like to note that neither our statistic, the 
number of expressed genes, nor the specific threshold ⊝ 
was crucial for our conclusion, but other statistics led to 
similar results. For our following analysis, it was impor-
tant only that there was a difference but not how each 
individual measure was affected. However, we thought 
that for particular measures that were used, e.g., as test 
statistic for hypothesis tests or distance metrics for clus-
tering, it might be interesting to quantify these differ-
ences more specifically.
Absolute expression of genes
In this analysis, we studied the influence of the sequenc-
ing depth on the number of expressed genes. The results 
for a TNBC-free patient (SRR1313211) and a TNBC 
patient (SRR1313133), exemplary for all samples stud-
ied, are shown in Fig. 5; the number of expressed genes 
Fig. 4 Comparison of the subsampling of reads via the DESIRE procedure (blue) and a direct scaling of count matrices (red). The obtained numbers 
of expressed genes depending on the sequencing depth for four different threshold parameters (1, 10, 50, 100) are shown.
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(Y axis), depending on the sequencing depth f (X axis) 
for different values of a threshold parameter ⊝ϵ{1, 10, 
50, 100}, are also presented. All results are for raw count 
values, not normalized values, and for each sequencing 
depth f, we generated R =  24 subsampled data sets for 
which box plots are shown.
The first impression of the overall behavior was intui-
tive because the larger was the sequencing depth, the 
higher was the probability to obtain at least ⊝ reads for 
a gene, if it was expressed. Less intuitive was the fact that 
for all samples and all thresholds, there was no saturation 
in the number of expressed genes, but this number con-
tinued to grow, which suggests that even the maximally 
available sequencing depth was not sufficient to achieve a 
saturation of the measurements. In addition, this pointed 
to possible errors in either the sequencing or the align-
ment of reads because it was biologically implausible 
to assume that almost all 23,648 genes considered by 
our analysis were actually expressed for ⊝ =  1 (Fig.  5). 
This may open the possibility to quantify such errors 
statistically.
From the obtained results in Fig.  5 and the results 
from 6 further samples that looked qualitatively simi-
lar (not shown), we attempted to estimate the opti-
mal sequencing depth in the following two ways using 
the available sequencing depth of the samples used for 
our analysis (TNBC samples: 34974017, 46677107, 
17574408, and 24440340; TNBC-free samples: 
25900791, 43454785, 31426867, and 33517581). Esti-
mator (I)—average sequencing depth: the first estima-
tor centers on average properties of our samples. Given 
that the average number of short reads per sample was 
32,245,737  ±  9,710,593 (averaged over the 8 samples) 
and the fact that none of the growth curves saturated, we 
estimated that the average number of reads necessary for 
a saturation must be larger than 32,245,737. Estimator 
(II)—individual sequencing depth: the second estimator 
centers on the individual samples. The largest sequenc-
ing depth of our samples was 46,677,107, and even this 
sample did not lead to a saturating growth. Hence, a 
conservative estimate requires an individual sequencing 
depth larger than 46,677,107.
The variability of all results, e.g., the interquartile 
range (IQR) of the box plots, was in general quite small. 
However, for larger ⊝ values, the IQR was even further 
decreased, which showed that the estimation for the 
number of expressed genes was even more stable for 
larger expression threshold values, corresponding to a 
more stringent filtering for expressed genes.
For a quantitative comparison between the TNBC and 
TNBC-free patient samples, we compared the mean of 
median values of the number of expressed genes, for dif-
ferent sequencing depths f, to test the null hypothesis:
by a two-sample t test. Each comparison was based on 4 
samples per condition. Here, for instance, medianTNBC|f 
indicates the conditional median value of TNBC patients, 
conditioned on the sequencing depth f. The other condi-
tional symbols have a similar meaning.
The results of these hypothesis tests are shown in 
Table  1. For a significance level of α  =  0.05, only one 
result for a left-sided test was significant for f = 0.1. How-
ever, all other P values from the left-sided comparison 
were approximately 5%, indicating a tendency of being 
different but not significantly. This is plausible because 
we know that the samples from TNBC and TNBC-free 
patients corresponded to two different physiological 
conditions but that these differences affected some, but 
not all, biological processes, e.g., the hallmarks of cancer 
[33]. Hence, if samples are compared as a whole, as in our 
case, using only the mean of the medians of the number 
of expressed genes as a test statistic and not adjusting for 
different types of biological processes, e.g., using infor-
mation from the gene ontology database [34], this signal 
is too weak to be detected. On the other hand, we found 
that the number of expressed genes in TNBC patients 
was smaller than that in TNBC-free patients because 
there was a clear asymmetry between the left- and right-
sided P values, always leading to the relation
This relation indicated that, on average, there were 
fewer genes expressed in TNBC patients than in the cor-
responding control samples, independent of the sequenc-
ing depth.
Growth rate of the number of expressed genes
Next, we compared the growth of the number of 
expressed genes depending on the sequencing depth 
(Fig. 5). For this reason, we fitted Gompertz growth func-
tions [35] given by
Here a, b, and c are parameters of the Gompertz function 
to be fitted and c is called the growth rate. For our quanti-
tative comparison, we used the fitted values of c.
We used Gompertz growth functions because the 
number of (expressed) genes of an organism was limited 
and, hence, so was the increase in the number of genes 
having more than a certain threshold needed to satu-
rate. Growth curves, such as the Gompertz function or 
the logistic function [36, 37], have the natural constraint 
of being limited from above and, hence, provide a natu-
ral choice for a constrained regression function. Table 2 
(5)
H0|f : mean(medianTNBC|f) = mean(medianTNBC-free|f)
(6)p valueleft-sided ≪ p valueright-sided
(7)f (x) = a exp (−b exp (−cx))
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shows the growth rates and their standard deviations for 
all 8 samples and the 4 threshold values, ⊝ϵ {1, 10, 50, 
100}.
From a visual inspection, there were only slight differ-
ences between the different conditions. For this reason, 
we quantified the results to test the null hypothesis that 
there was no difference in the values of the growth rates, 
i.e.,
(8)H0|f : mean(cTNBC|f) = mean(cTNBC-free|f),
Fig. 5 Triple‑negative breast cancer (TNBC)‑free sample SRR1313211 and TNBC sample SRR1313133. The number of expressed genes for different 
filtering thresholds (1, 10, 50, 100) depends on the sequencing depth. The blue curves correspond to fitted Gompertz functions. All results are for raw 
(unnormalized) count values.
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for depth by a two-sample t test. Again, each comparison 
was based on 4 samples per condition.
To identify direction-specific effects, we also per-
formed hypothesis tests for two-sided, left-sided, and 
right-sided comparisons. The results of these hypothesis 
tests are shown in Table 3. Overall, for a significance level 
of α =  0.05, none of these hypothesis tests was signifi-
cant. However, the right-sided P values were not much 
larger than 0.05, hinting at a tendency in the data to be 
different, like the comparison of the median number of 
expressed genes above.
A normalization of the data does not remove the 
growth property observed in Fig. 5, but normalized data 
exhibit qualitatively the same behavior. For ⊝ =  1, this 
was obvious because the normalization led to a scaling of 
the data without changing the zero values. For ⊝ > 1, it 
was less intuitive but followed from our numerical analy-
sis (results not shown).
Distributional shape of expressed genes
Last, we studied the distributional shape of expressed 
gene values (and not of their numbers) by estimating 
individually for each parameter configuration its mean 
value, variance, skewness, and kurtosis. Here, we mean 
the distribution over all genes within a sample, and not 
the count distribution of individual genes across samples. 
Because every distribution with existing moments was 
fully characterized by all of its moments, either via its 
moment-generating function or via its probability gen-
erating function [38, 39], our analysis was an approxima-
tion of the distributional shape because we limited our 
focus to 4 dimensions.
Specifically, for each condition (TNBC versus TNBC-
free) and each sequencing depth (f ϵ {1, 10, 50, 100}), we 
Table 1 Results of two-sample t tests comparing the total 
number of expressed genes for various sequencing depths
The total number of expressed genes for various sequencing depths is shown 
in Fig. 5.
Depth P value,  
two-sided




0.1 0.096,85 0.048,45 0.951,57
0.2 0.125,02 0.062,51 0.937,49
0.3 0.124,18 0.062,10 0.937,91
0.4 0.123,61 0.061,81 0.938,19
0.5 0.118,90 0.059,45 0.940,55
0.6 0.128,56 0.064,28 0.935,72
0.7 0.145,83 0.072,92 0.927,08
0.8 0.161,76 0.080,88 0.919,12
0.9 0.155,24 0.077,62 0.922,38
Table 2 Fitted growth factor values and  standard devia-
tions for the Gompertz functions
TNBC triple-negative breast cancer and SD standard deviation.
Depth Sample Condition Growth rate (SD)
1 SRR1313137 TNBC 18,645.168 (71.428)
1 SRR1313135 TNBC 19,218.431 (51.492)
1 SRR1313134 TNBC 18,885.949 (71.780)
1 SRR1313133 TNBC 18,993.399 (58.036)
1 SRR1313211 TNBC‑free 18,615.636 (77.401)
1 SRR1313214 TNBC‑free 18,726.438 (82.876)
1 SRR1313219 TNBC‑free 18,286.856 (82.281)
1 SRR1313220 TNBC‑free 18,930.056 (85.636)
10 SRR1313137 TNBC 14,904.344 (144.082)
10 SRR1313135 TNBC 16,096.457 (121.821)
10 SRR1313134 TNBC 15,053.704 (139.567)
10 SRR1313133 TNBC 15,592.711 (155.879)
10 SRR1313211 TNBC‑free 14,756.491 (152.976)
10 SRR1313214 TNBC‑free 14,740.701 (158.437)
10 SRR1313219 TNBC‑free 13,971.554 (166.406)
10 SRR1313220 TNBC‑free 15,280.019 (143.239)
50 SRR1313137 TNBC 11,532.85 (163.987)
50 SRR1313135 TNBC 12,782.861 (162.683)
50 SRR1313134 TNBC 11,211.735 (166.459)
50 SRR1313133 TNBC 12,170.85 (205.805)
50 SRR1313211 TNBC‑free 11,336.443 (195.497)
50 SRR1313214 TNBC‑free 11,514.378 (174.158)
50 SRR1313219 TNBC‑free 10,577.339 (166.987)
50 SRR1313220 TNBC‑free 11,654.075 (193.834)
100 SRR1313137 TNBC 9,983.466 (176.904)
100 SRR1313135 TNBC 11,235.174 (168.548)
100 SRR1313134 TNBC 9,634.957 (198.902)
100 SRR1313133 TNBC 10,398.413 (194.712)
100 SRR1313211 TNBC‑free 9,654.874 (175.648)
100 SRR1313214 TNBC‑free 9,898.436 (162.635)
100 SRR1313219 TNBC‑free 9,089.057 (145.683)
100 SRR1313220 TNBC‑free 9,947.798 (162.972)
Table 3 Results from comparing the growth rates of the fit-
ted Gompertz functions for TNBC and TNBC-free patients
The Gompertz functions for TNBC and TNBC-free patients are shown in Table 2. 
Abbreviation as in Table 2.
Depth P value,  
two-sided




1 0.151,2 0.924,4 0.075,6
10 0.107,2 0.946,4 0.053,6
50 0.179,5 0.910,2 0.089,8
100 0.157,4 0.921,3 0.078,7
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generated R = 24 data sets, giving a total of 432 data sets, 
and applied the expression threshold ⊝ = 1 to each data 
set as a filter. In the following analysis, we distinguished 
between CPM normalized and raw (unnormalized) data 
by estimating the mean, variance, skewness, and kurtosis 
of the distributions of expression values of the genes. The 
results of this analysis are shown in Fig.  6 and Tables  4 
and 5, which include results for raw (unnormalized) data 
in Columns 3 and 4. The first observation from Fig. 6 is 
that a normalization of the data was absolutely neces-
sary to obtain stable results across different sequencing 
depths. This is clearly visible for the mean and variance 
values because they showed increasing values for larger 
sequencing depths. In this respect, even a simple CPM 
normalization counterbalanced this effect, leading to 
stable expression patterns across different sequencing 
depths. This also illustrated that the choice of normali-
zation method affected the statistical properties of a 
Fig. 6 Results for the 4 moments: mean, variance, skewness, and kurtosis (rows). Columns 1 and 2: normalized data; Columns 3 and 4: raw data; 
Columns 1 and 3: TNBC patients; Columns 2 and 4: TNBC‑free patients.
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distribution and the results of statistical inference sig-
nificantly, such as differential gene expression analysis, 
which was also observed [15]. From a visual compari-
son of the moments for TNBC and TNBC-free patients, 
we observed clear differences between the variance, 
less clear differences for the kurtosis and neutral differ-
ences for the mean and skewness. For a quantification 
of the comparison between the moments for TNBC and 
TNBC-free patients, we tested the following null hypoth-
esis by a two-sample t test:
for depth f and mϵ{mean, variance, skewness, kurtosis}, 
indicating the four moments we studied. Each compari-
son was based on nine samples per condition because we 
pooled the median values across the different sequenc-
ing depths for each condition and each measure m. The 
results of this analysis are shown in Table 6. Overall, the 
mean values were essentially undistinguishable (with P 
values of approximately 1.0) but the other three moments 
were significantly different at a two-sided significance 
level of α = 0.05. Specifically, for the kurtosis and skew-
ness, the left-sided tests were significant; for the variance, 
the right-sided test was significant. That means that for 
kurtosis and skewness, the values of the moments were 
higher in TNBC-free patients than in TNBC patients, 
whereas for variance, these values were lower. This result 
is interesting because, commonly, a disease is associated 
with instability or disorder, but a decreasing variance 
suggested less variability in the expression values of the 
genes.
Discussion
In this paper, we studied various effects of differing 
sequencing depth on distributional aspects of gene 
expression data obtained from RNA-seq experiments. 
From our analysis, we found 3 main results.
1. The subsampling of RNA-seq data gave biologically 
realistic simulations of next-generation sequenc-
ing experiments with smaller sequencing depth, 
but a direct scaling of count matrices did not. This 
is an important finding because, first of all, it dem-
onstrated that the conceptually simpler and compu-
tationally more efficient approach of a direct scaling 
of count matrices led to data sets with an unclear 
biological interpretation. This is of course a major 
problem because whatever results were obtained 
(9)H0|f : mean(mTNBC|f) = mean(mTNBC-free|f),
Table 4 Moments for TNBC-free patients
The moments for TNBC-free patients are also presented in Fig. 6. Abbreviations 
as in Table 2.
Depth Mean (SD) Variance (SD) Skewness (SD) Kurtosis (SD)
0.1 42.29 (0) 29,616.28 
(2,817.52)
18.51 (2.75) 599.44 (222.29)
0.2 42.29 (0) 29,588.5  
(2,790.57)
18.48 (2.71) 597.09 (219.38)
0.3 42.29 (0) 29,600.99 
(2,803.23)
18.50 (2.71) 598.63 (219.27)
0.4 42.29 (0) 29,602.40 
(2,819.85)
18.51 (2.72) 598.92 (220.32)
0.5 42.29 (0) 29,592.22 
(2,807.72)
18.49 (2.71) 597.70 (218.81)
0.6 42.29 (0) 29,597.76 
(2,805.76)
18.50 (2.71) 598.30 (219.30)
0.7 42.29 (0) 29,599.37 
(2,807.41)
18.51 (2.72) 599.09 (220.33)
0.8 42.29 (0) 29,595.86 
(2,805.56)
18.51 (2.72) 598.86 (220.13)
0.9 42.29 (0) 29,593.61 
(2,806.58)
18.50 (2.71) 598.45 (219.59)
Table 5 Moments for TNBC patients
The moments for TNBC patients are also presented in Fig. 6. Abbreviations as in 
Table 2.
Depth Mean (SD) Variance (SD) Skewness (SD) Kurtosis (SD)
0.1 42.29 (0) 23,176.53 
(5446.28)
17.99 (7.33) 759.6 (618.96)
0.2 42.29 (0) 23,172.85 
(5454.44)
18.01 (7.33) 760.33 (618.23)
0.3 42.29 (0) 23,155.44 
(5437.48)
17.99 (7.34) 758.8 (620.44)
0.4 42.29 (0) 23,169.84 
(5448.77)
18.02 (7.35) 761.69 (621.23)
0.5 42.29 (0) 23,165.79 
(5448.29)
18.01 (7.34) 760.62 (620.49)
0.6 42.29 (0) 23,166.48 
(5449.83)
18.01 (7.35) 760.84 (621.57)
0.7 42.29 (0) 23,168.39 
(5451.98)
18.02 (7.35) 761.56 (621.74)
0.8 42.29 (0) 23,165.7  
(5448.48)
18.02 (7.35) 761.45 (621.81)
0.9 42.29 (0) 23,164.67 
(5448.95)
18.01 (7.35) 761.16 (621.53)
Table 6 Results from  pooled (across different sequencing 
depths) two-sample t tests for the 4 moments of the gene 
expression distributions
The 4 moments of the gene expression distributions are shown in Fig. 6.
Moment P value,  
two-sided
P value,  
left-sided
P value,  
right-sided
Mean 1.0 1.0 1.0
Variance 2.238800e−11 1.000000e + 00 1.119400e−11
Kurtosis 1.966589e−04 9.832945e−05 9.999017e−01
Skewness 6.808568e−03 3.404284e−0.3 9.965957e−01
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from such data sets, e.g., using them for identify-
ing differentially expressed genes, the meaning is at 
best unclear and possibly even uninterruptable in 
the sense that replicated next-generation sequenc-
ing experiments would not result in data with such a 
characteristic.
2. To obtain saturating results, we estimated an aver-
age sequencing depth of >32 million reads and an 
individual sequencing depth of >46 million reads. 
The literature gives context-specific suggestions. For 
instance, for detecting rare transcripts in human, 
>200 million paired-end reads should be used, and 
for the accurate quantification of genes across the 
entire expression range, >80 million reads per sample 
should be used [29, 40]. However, for the identifica-
tion of differentially expressed genes, 36 million reads 
per sample may be sufficient [29].
 For future studies, it would be interesting to derive 
improved bounds for optimal sequencing depths 
with respect to two complementary aspects. The 
first aspect involves distinguishing different applica-
tion domains because the optimal sequencing depth 
is likely to depend on the bioinformatics analysis. For 
gene expression data from DNA microarray experi-
ments, such differences have already been known 
for, e.g., methods identifying differentially expressed 
genes and methods for identifying differentially 
expressed gene sets [41–43]. Second, in this study, we 
considered only simple statistical estimators for the 
optimal sequencing depth; however, more elaborate 
approaches are possible, e.g., by exploiting the results 
from the fitted growth curves.
3. For an abrogated feature selection, i.e., using all 
expressed genes that have read counts of ⊝  =  1 
or larger, the higher moments of the distribution 
of expressed genes showed a much better sensi-
tivity for the signal detection of differing pheno-
typic conditions than the corresponding mean 
values (Table  6). This could be further explored 
by designing statistical tests that use such higher 
moments as a test statistic. A potential advantage 
of such tests over, e.g., the conventional mean-
based tests such as a t test or ANOVA could be a 
reduced need in sample size, as suggested by our 
results. However, this requires a further detailed 
analysis.
Conclusions
The subsampling of RNA-seq data allows us to explore 
important aspects of gene expression data. These must be 
understood before such high-throughput data types can 
be used for applications in translational medicine.
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